Status: Recruiting
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
The primary objective of this research study is to evaluate the effect of tirzepatide, relative to placebo, as an adjunct to BUP on retention, substance use, and sleep outcomes in individuals with OUD.
Participants needed: 310
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: T. John Winhusen, PhDUpdated: May 22, 2026Locations: 9
Eligibility criteria
Must be ≥18 years of age; [+9]
have a history of type 1 or type 2 diabetes mellitus (other than pregnancy-relat... [+11]